Takeda

Dizal Breaks New Ground for EGFR Drugs in Lung Cancer

Takeda Breaks Up With Denali, Dumps Dementia Drug

Daito Pharmaceutical Posts 86% Nine‑Month Profit Surge on New Drug Sales

Pharma and Biotech Layoffs 2026 Watch

Spyre Therapeutics Jumps 25% on Positive Phase 2 SKYLINE Data

JPM26: Protagonist Has a $400M Decision To Make. It’s a No-Brainer

Top 20 Fastest Growing Pharma & Biotech Companies in the Americas for 2026

Senju Launches First-in-Class Dry Eye Disease Drug in Japan

The Company that Built TikTok’s Algorithm Is Now Designing Drugs for Diseases Pharma Called Undruggable

JPM26: Filling C-Suites, Union Square—And Elevators—With Pink

More Pharma Dealmaking; FDA’s Proposed Budget; Takeda Ends Partnership; and More

Proteasomes: A Novel Approach to Target the Immune System

CMS's Medicare Price Negotiations Start Round Three

Mezagitamab Shows Promise in Treating Immune Thrombocytopenia Patients

Are We Ready for the Next Wave of Proximity Degraders?

Biopharmas Pull Back on Layoffs in Q1

ByteDance’s Anew Labs Unveils First AI‑Designed Small‑Molecule Immunotherapy

How Real-World Evidence Is Shaping Inclusive Clinical Trials with Takeda CMO Dr. Awny Farajallah — Episode 257

EU Approves Otsuka's Long-Acting HAE Drug Dawnzera

The FDA Has Released Draft Guidance for NAMs Validation – Now What?

11 Companies Hiring Manufacturing Professionals Now

Hiring Outlook: February Brings First YOY Job Increase Since 2022

Multiple Myeloma Drug Blenrep Backed for Wider NHS Use

More Changes Ahead for Takeda with New CEO Set to Take Reins

Wave To Work Alone on RNA Editor as AATD Picture Becomes Clearer

PDA Week 2026 Showcased AI, Knowledge Management, and Proactive Quality Culture

UK Names Health Data Chief, as BIA Finds Its New CEO

Alumis Soars as TYK2 Drug Hits Mark in Psoriasis Trials

Denali Regains Full Rights to Frontotemporal Dementia Therapy as Takeda Exits DNL593 Pact

DDW 2026: Key Readouts From the Conference

Protagonist’s First Approval Spells Trouble for Pharma’s Immunology Heavyweights

Intellia Files FDA BLA After Phase 3 Shows 87% Cut in HAE Attacks

VIDEO: ‘New Era of Oral Therapies’ on Horizon in Psoriasis

Pig Liver Xenotransplant Shows Promise, but More Work Remains

Pharma Pipeline Stalls for First Time in Decades: Citeline

Is Algae The Answer To Carbon Capture? Intrinsic Foundries’ Green Fix For Toxic Waste

FDA Kicks Off Review of Takeda's Narcolepsy Hopeful

Halozyme Diversifies in Drug Delivery with Surf Bio Buy

Takeda’s TAK-881 Shows Comparable Efficacy in PID Trial

Takeda, Iambic Sign Multiyear R&D Deal for AI Drug Discovery

Abivax in No Rush for a Deal, Confident Key June Trial Data Can Secure Better Terms for Partnerships, CEO Tells CNBC

Teclistamab as Monotherapy Shows Huge Advantage After First Relapse in Myeloma

World Schizophrenia Day 2026: New Data, Tests & Treatment Targets

BioSpace’s NextGen Class of 2026 Attracts Big Bucks From Tight Wallets

Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs

The Next Cambridge? LA Sets Its Sights Higher

JPM26: KalVista’s HAE Win Is a ‘Tale of Two Markets’

Women Business Leaders on How To Solve AI’s Inclusivity Problem

‘Over and Above’ Responses Seen with Envudeucitinib for Plaque Psoriasis

Zelestra Brings Spanish 162MW Solar PV Portfolio Online